ORMP
NASDAQ · Pharmaceuticals
Oramed Pharmaceuticals Inc
$3.95
-0.03 (-0.75%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+141.8% upside
Low Target
$5.95
Average Target
$9.55
High Target
$10.69
Current Price
$3.95
Current
$3.95
$3.95
Target
$9.55
$9.55
$5.95
$9.55 avg
$10.69
Scenario Analysis
Bear Case
$5.95
50.6%
Low target
Base Case
$9.55
+141.8%
Avg target
Bull Case
$10.69
+170.6%
High target
Risk/Reward
3.4x
Highly favorable
Price in Context
52-Week High
$4.22
-6.4% from high
52-Week Low
$1.98
+100.0% from low
Target vs 52W High
$9.55
+126.3% vs high
Peer Consensus — Pharmaceuticals